ABSTRACT Motivation: Standard analysis routines for microarray data aim at differentially expressed genes. In this paper, we address the complementary problem of detecting sets of differentially co-expressed genes in two phenotypically distinct sets of expression profiles. Results: We introduce a score for differential co-expression and suggest a computationally efficient algorithm for finding high scoring sets of genes. The use of our novel method is demonstrated in the context of simulations and on real expression data from a clinical study.
INTRODUCTION
Gene expression is a tightly regulated process, crucial for the proper functioning of a cell. In microarray data, co-regulation is reflected by strong correlations between expression levels (Eisen et al., 1998) . Molecular disease mechanisms typically constitute abnormalities in the co-regulation of genes (Golub et al., 1999) . Resulting changes in expression profiles help to identifying disease-related genes and in several cases facilitate improved diagnosis (West et al., 2001; Yeoh et al., 2002) and even prognosis of disease outcome (van't Veer et al., 2002; Huang et al., 2003) . Alteration of gene regulation often results in up-or down-regulated genes. Common analysis strategies look for these differentially expressed genes or for genes, which play an important role in some supervised learning algorithm.
We opt to use a complementary approach. Not all changes in co-regulation are manifested by up-or down-regulation of individual genes. We illustrate this point in Figure 1 . Figure 1a displays differentially co-expressed genes, while the genes in Figure 1b are differentially expressed. Columns refer to patients, rows to genes and gray levels to expression values. Both plots are vertically split into two parts, where the lefthand side corresponds to patients from a control group and the right-hand side to patients from a disease group. Differential gene expression is shown nicely in Figure 1b . Figure 1a shows no differentially expressed genes; the average expression of * To whom correspondence should be addressed. all genes is almost identical in both groups. However, one still observes a striking difference between the two groups: the control displays co-expression structure in the form of a stripe pattern, which appears to be lost in the disease group. In mathematical terms, differential gene expression aims at changes in first-order moments (means), while our approach opts for changes in second-order moments (covariances). In this paper, we will show that patterns like those in plot (a) can be observed in real expression data, and we propose a first algorithm to detect them. To our knowledge, this structure in microarray data has not yet been discussed in the literature; we believe and will demonstrate that established analysis approaches, such as clustering and supervised learning in general fail to identify it.
In contrast to differential expression, differential coexpression cannot be analyzed gene by gene. One needs to take into account all possible subsets of genes. The challenge then is to efficiently screen the astronomically large number of subsets. We suggest to use an additive model for scoring co-expression, which allows for a more efficient search than standard correlation coefficients.
In Section 2, we derive a score for differential co-expression based on this model and present an efficient algorithm for finding high scoring sets of genes. In Section 3, we first demonstrate the performance of the algorithm on simulated data.
Then we apply our procedure to a public set of microarray data from acute pediatric lymphoblastic leukemia patients (Yeoh et al., 2002) . As a step toward assessing the statistical significance of our findings we apply a permutation procedure. We also demonstrate and explain why established analysis strategies, both supervised and unsupervised, are not suitable for detecting the patterns we target.
METHODS

A score for differential co-expression
We are interested in finding groups of genes, which show differences in their correlation structure conditioned on two different class labels. We summarize the normalized expression data in a matrix A, with entry a ij being the expression level of gene i in patient j . Let a group of patients be denoted by J and and let I denote a subset of genes. We consider the additive model 
A group of genes with a low score S is highly correlated, and S increases as this mutual correlation decreases. The reason for preferring S over the standard correlation coefficient is that S allows for a more efficient search for high-scoring gene sets. Given a set of genes I and a candidate gene k, Cheng et al. (2000) demonstrate that one can tell how including or excluding this gene will affect the score without having to refit the model (1). Next, we adopt the score to our setting of differentially co-expressed genes. Given two groups J 1 and J 2 , e.g. disease and control, we suggest minimizing the score
ij ) 2 over all subsets of genes I . The superscripts {(1), (2)} emphasize that the parameter estimates are different for the two Algorithm 1. A greedy downhill approach for finding local minima of the score S. A random starting point I is chosen. The neighborhood N (I ) is explored using the criterion C k (α) defined in Equation (2). Downhill steps are taken, possibly several at a time, before S(I ) is recalculated. This is repeated until no further downhill directions are found, or until a predefined number of iterations is exceeded. The operator denotes the symmetric difference of two sets. groups and will be omitted further on. We target the gene sets described in the Introduction. Sets with low scores S are coexpressed in the samples belonging to J 1 , but not in samples belonging to J 2 .
A stochastic search algorithm for low-scoring gene sets
Rigorous minimization of S is hard. We will not address this optimization problem, but will confine ourselves to describing a heuristic algorithm for finding low-scoring sets of genes. The general framework is that of a stochastic greedy downhill procedure (Algorithm 1). We begin by equipping the set of all possible subsets of genes on the array with a neighborhood structure. We define two sets of genes as neighbors, if and only if they can be converted into each other via inclusion or exclusion of a single gene. The general strategy of the downhill procedure is as follows: starting with a random set of genes I , we move to neighboring sets taking downhill directions, i.e. including or excluding single genes such that the score S decreases. This is repeated until no more downhill directions are found or a predefined number of iterations is exceeded. Two important points need to be addressed, one related to computational efficiency and a second one related to the size of the target gene set I .
Evaluating S for a candidate gene set I requires recalculating all column means as well as the squared residuals. For large datasets, this is computationally too demanding and renders a search impractical. We modify a technique described in Cheng et al. (2000) to solve this problem: for the score S , Cheng et al. (2000) derive a computationally efficient criterion for the inclusion or exclusion of a gene, which guarantees that S will be reduced by this action, and which does not require the updating of the model. For the novel score S there is a similar criterion at hand: consider we are given a set of genes I and want to investigate the effect of excluding gene k. We have
where I (−k) denotes the gene set I without gene k. Using the abbreviations introduced above this implies
k > S(I ). Unfortunately, in generalS k = S(I (−k) ), since refitting the parameters of the additive model also has an effect on S(I (−k) ). Nevertheless, we use this criterion to decide whether to exclude gene k from I or not. Simulation results show that S generally drops, although there is a theoretical possibility that it does not (data not shown). Deriving a criterion for including a gene not present in I goes along the same lines and yields
Using the criterion above, we explore the neighborhood N (I ) of I by calculating the B k instead of S(I ) for all I in N (I ). This is computationally cheaper than refitting the whole model, and the gain in computation time is critical for the practicality of the algorithm. Further speedup is achieved by going several steps at a time. We collect all genes in the neighborhood of I that meet the criterion for a diminished score. From these genes, we randomly choose a predefined fraction β and exclude or include them at once. From simulations (data not shown), we choose β = 0.01 as a trade off between efficiency and robustness. The randomization of both, the start set and the choice of downhill directions, results in different identified gene sets belonging to different local minima of S. This feature is highly useful for exploratory analysis, since in large datasets we expect more than one relevant pattern.
A second point is related to the size of the target gene set I . In general, there will practically always exist a k, such that B
(1) k /B (2) k > S I and one would eventually exclude all genes from I . Therefore, we introduce a modified criterion using a compensating term, similar to what Yang et al. (2003) did to S . This yields the following rule: include or exclude gene k, if
where α is a tuning parameter in [0, 1]. It weights a penalty term for excluding too many genes and therefore influences the size of the final set of genes. Larger values of α yield smaller groups of genes and vice versa. Algorithm 1 summarizes the overall procedure.
RESULTS
Simulations
We first evaluate the algorithm in a supervised setting. We generate a control group of 10 samples and a disease group of another 10 samples, both consisting of 120 genes. For the control group, 20 co-expressed genes are sampled directly from the additive model (1). We first draw a vector of 20 row effects b i and a vector of 10 column effects c j from a standard normal distribution. The actual expression levels are obtained by adding independent errors sampled from a normal distribution with mean zero and SD σ . These 20 genes form the target pattern. We then hide them in 100 additional noise genes, which are sampled i.i.d. from a standard normal distribution. The disease group is simulated by 120 independent noise genes drawn from a standard normal only.
In the above setting, we are left with the parameter σ to tune the strength of the signal resulting from the 20 coexpressed genes. We use three different values: for a clear signal σ = 1/10, for medium noise σ = 1/4 and for high noise σ = 1. In each case, data are generated and gene sets are calculated by our algorithm, taking three random restarts and choosing the result with the lowest score S. We use a range of parameters α, observing their effect. To guard for sampling effects, we repeat each procedure 50 times and average the results, which are displayed in Figure 2 .
One can see that for the clear and medium signal the algorithm manages to recover the differentially co-expressed genes reliably. Also, depending on the prominence of the signal, the influence of α is more or less pronounced. In an exploratory analysis setting with several hidden patterns, one would like to use α to control the size of target patterns. From Figure 2 we deduce that one can reasonably do this, and more safely so when avoiding extreme values.
Clinical data
As a first real-world application, we choose a dataset from a study on acute lymphoblastic leukemia (Yeoh et al., 2002) . Affymetrix HG-U95Av2 chips are used to measure the gene expression levels in bone marrow from children with acute leukemia. The dataset consists of 327 samples, which are divided into several subgroups according to characteristic cytogenetic aberrations. This includes a normal group of leukemia patients where no such aberrations are found. We compare all cytogenetic positive groups (disease groups) to leukemia without cytogenetic alterations (control). First, we normalize and variance stabilize (Huber et al., 2002) the expression data. For computational efficiency, we calculate the absolute deviation from the median for all genes and discard the lower 50% of them. It is important to note that the score S is not scale invariant. We rescale the genes separately for each phenotypical group to SD 1. Otherwise, the algorithm fails to detect differential co-expression patterns; instead high-scoring gene sets show differential variances of single genes. After rescaling, the algorithm is less sensitive to gene-specific changes in variance.
We found patterns reflecting differential co-expression in almost all analyses of cytogenetically characterized leukemias. In this paper, we confine ourselves to the discussion of a single illustrative example. We compare philadelphia positive [t(9;22)+, BCR-ABL+] leukemias to the cytogenetically normal group, choosing α = 0.5.
The most prominent local minimum of S is shown in Figure 3 . Figure 3a shows an image of the expression matrix of the scaled genes. One can see stripes indicating co-expression of genes in the normal group, which is obviously lost in philadelphia positive patients. Figure 3b shows histograms of pairwise correlation coefficients of the genes; in the upper half the samples are taken from the control group and in the lower half from the disease group. In the upper half of Figure 3c , the expression profiles of the unscaled genes are depicted. Samples of the control group are on the left, samples of the philadelphia positive group on the right. The lower half shows scaled data where the row means a i• according to model (1) are subtracted. One can see in all the plots that we have found a group of genes displaying the characteristic pattern we are looking for.
Excluding the genes that form our pattern from the data and applying the algorithm again, we end up with a cluster of genes reflecting a different local minimum. The list of genes corresponding to the two patterns is shown in Table 1 . 
Significance and comparison to established methods
Naturally, the question arises whether our findings are artifacts of the high dimensionality of the data. To assess this question, we apply a permutation procedure. Under the null hypothesis, we assume that all genes are mutually independent in both phenotypical groups. We heuristically sample from the null hypothesis by (group wise) shuffling the expression values for each gene independently. Thus random expression data are generated where all covariance structure is removed. Applying our algorithm to the randomized data yields one random score S per permutation. We repeat the procedure 1000 times. Using the empirical distribution of the simulated scores, we calculate p-values for the observed scores in the non-permuted data. For each of the patterns in the leukemia example, we only observe one random score smaller than the biological one. This corresponds to an empirical p-value of 0.001. Hence, it is unlikely that the observed differential co-expression is a chance artifact. Next, we show that our algorithm is complementary to established analysis tools. It aims for specific structure in microarray data that other methods fail to identify. Of course, (90634) RHEB (6009) ARHGDIB (397) NCL (4691) EXO70 (23265) KARS (3735) KIAA1579 (55225) SRP19 (6728) RNF4 (6047) HCP15 (157317) HNRPA2B1 (3181) RNP24 (10959) ECHS1 (1892) C9orf10 (23196) REA (11331) UGP2 (7360) GNAS (2778) GNAS (2778) OTOR (56914) COPE (11316) ATP5A1 (498) ATP5J2 (9551) PTOV1 (53635) YWHAQ (10971) CBFB (865) HLA-Z (267017) COX6A1 (1337) STARD7 (56910) CALM2 (805) PPP2R1A (5518) Pattern 2 (21 genes) PSMB2 (5690) UBC (7316) ARHA (387) PSMA4 (5685) ARPC2 (10109) ACTB (60) ENG (2022) GG2-1 (25816) ACTR3 (10096) PITPNB (23760) CAPNS1 (826) PFN1 (5216) SF3B2 (10992) GNAI2 (2771) ARHA (387) PPP1CC (5501) PSMC5 (5705) ARPC5 (10092) MRLC2 (103910) AES (166) GDI2 (2665) the literature on microarray data analysis is huge and we cannot discuss all of it in detail. We confine ourself to showing that the most widely used approaches, namely screening for differential expression and hierarchical clustering, do not identify differential co-expression structure. To address differential expression, we sort all genes according to their individual t-scores. This shows the genes from our first pattern to be ranked from 106 to 6114 with a mean of 2340. Clearly, this list would not draw attention to the genes in the pattern.
We also calculate a hierarchical clustering of the expression data using euclidean distance and average linkage (Eisen et al., 1998) . The complete results are too complex to display. Therefore, we aggregate genes in a first clustering step choosing 100 representatives for clusters. These we cluster again hierarchically as shown in Figure 4 . The dots indicate clusters that contain genes from our most prominent differential co-expression pattern. Figure 4a shows the results for unscaled data, Figure 4b for scaled. In both cases, one can clearly see how the genes are distributed all over the first half of the dendrogram.
DISCUSSION
We have addressed the problem of detecting sets of genes, which are differentially co-expressed in two phenotypically different groups of expression profiles. We have proposed a score for measuring differential co-expression based on an additive model and have described a heuristic algorithm for finding high-scoring gene sets. The algorithm performs well in detecting target patterns, as we have shown on simulated data. Using a real-world example, we have demonstrated that differential co-expression patterns exist and that our algorithm detects them.
We have stressed our belief that other data analysis tools fail to identify patterns characteristic for differential co-expression. Of course, any evaluation of available methodology in a single paper must be incomplete and we have only verified this for two approaches. Also, we did not find the detection of differential co-expression as an explicit objective in the literature. The vast majority of supervised analysis tools aims at changes in means. Clustering aims at consistent, not at differential co-expression. Of course, several analysis models, such as discriminant analysis, neural networks, support vector machines and many others take the covariance structure of the data into account, possibly respecting differences in the two groups. But they do not aim at detecting target patterns like we do.
Our method is exploratory in the sense that we can neither guarantee to find the optimal scoring set of genes nor derive rigorous statistical tests for the significance of score levels. This is due to the fact that the scores on the randomized data also result from a heuristic search. Nevertheless, our procedure can be used as a tool for the exploratory analysis of microarray data, complementing the frequently used clustering procedures. Its purpose is hypothesis generation, not hypothesis verification.
Any interpretation of exploratory analyses is speculative, and further biological experiments are needed for verification. In our analysis of philadelphia positive leukemias, we detected two differential co-expression patterns, containing several genes of the proteasome-ubiquitin pathway, namely PSMB1, PSMA2, PSMB2, PSMA4, PSMC5 and UBC. The proteasome plays a central role in the regulation of proteins that control cell-cycle progression and apoptosis (Adams, 2003) . For various cancer types it has been shown that inhibition of proteasome activity results in programmed cell death, and it has therefore become an important target for anticancer therapy (Adams, 2003) . Particularly, a study on chronic lymphoblastic leukemias (CLL) shows, that CLL-derived lymphocytes are hyper sensitive to proteasome inhibition (by lactacystin) as compared with normal human lymphocytes (Masdehors et al., 1999) . Another interesting gene in the pattern is YWHAQ, coding a 14-3-3 protein. Fujita et al. (2002) show that the protein Akt phosphorylates p27, a prognostic tumor marker, and thereby promotes binding of 14-3-3 allowing degradation of p27 by the proteasome. Increased degradation of p27 is associated with decreased overall survival in mantle cell lymphoma, another B-cell malignancy (Chiarle et al., 2000) .
Recalling our method, it is important to note that genes in differential co-expression patterns can only be interpreted in the context of the other genes in the set that form the pattern. In our case, one functional group of genes is associated with intracellular protein transport and cellular localization, including SRP19, RNP24, COPE, FNTA and GDI2. This group of genes is functionally more heterogeneous than the proteasome associated proteins. But altogether one expects protein synthesis, protein transport and protein degradation to be highly coordinated processes.
It is interesting that our algorithm directly led us into a very active field of cancer research. In the light of this observation, we are confident that our method has a high potential for generating relevant hypotheses in biological and clinical research.
